2019 POC Clinical Chemistry and Immunodiagnostic Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 100 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

The author's new report provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

• Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.


• Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:


• Physician Offices/Group Practices


• Emergency Rooms


• Operating/Recovery Suites


• ICUs/CCUs


• Cancer Clinics


• Ambulatory Care Centers


• Surgery Centers


• Nursing Homes


• Birth Centers

Sales and Market Share Analysis

• Sales and market shares of major reagent and instrument suppliers.

Routine Clinical Chemistry Tests
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes
(Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests
Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests
C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

• Emerging technologies and their applications for POC testing.


• Comprehensive listings of companies developing or marketing POC diagnostic technologies, and products, by test.

Strategic Recommendations

• Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.


• Design criteria for POC testing products.


• Alternative business expansion strategies.


• Potential market entry barriers and risks.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

The companies analyzed in the report include:

• Abbott


• Accriva


• Agilent Technologies


• Axis-Shield


• Beckman Coulter/Danaher


• Becton Dickinson


• Bio/Data


• bioMerieux


• Bio-Rad


• Cepheid


• Chrono-Log


• Corgenix


• Decode Genetics


• Diagnostica Stago


• Diamedix


• DiaSorin


• Eiken Chemical


• EKF Diagnostics


• Fujirebio


• Grifols


• Helena Laboratories


• Hologic


• Horiba


• Instrumentation Laboratory/Werfen


• Kyowa Medex


• Leica Biosystems


• Lonza


• Nihon Kohden


• Ortho-Clinical Diagnostics


• Polymedco


• Qiagen


• Roche


• SDIX


• Sekisui Diagnostics


• Sequenom


• Siemens Healthineers


• Sienco


• Sysmex


• Takara Bio


• Thermo Fisher


• Tosoh


• Wako